UPDATE: Withdrawn hip PMA was "purely a business decision," says J&J

February 16, 2012 by MassDevice staff

Johnson & Johnson responds to the latest ballyhoo over sales of its recalled metal-on-metal hip resurfacing implants, which were sold overseas for a year after being rejected for sale on the U.S. market.

Hip X-ray

Johnson & Johnson's (NYSE:JNJ) metal-on-metal hip resurfacing implants stayed on the market in Europe and other countries after they were rejected for sale on the U.S. market, according to a report from the New York Times.

The implants were sold to patients overseas for 1 year after they were prohibited for U.S. patients, until they were recalled in August 2010 amid concerns about high failure rates.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.